Published in J Clin Invest on February 01, 1975
Human neutrophil Fc gamma receptor distribution and structure. Proc Natl Acad Sci U S A (1982) 6.54
Immune interferon induces the receptor for monomeric IgG1 on human monocytic and myeloid cells. J Exp Med (1983) 2.93
Variant von Willebrand's disease: characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets. J Clin Invest (1980) 2.88
Characterizaiton of two populations of human lymphocytes bearing easily detectable surface immunoglobulin. J Clin Invest (1975) 2.78
Suppression of leukocyte chemotaxis by human IgA myeloma components. J Exp Med (1976) 2.77
The structure and function of human IgA. Biochem J (1990) 2.65
A subpopulation of normal human peripheral B lymphcytes that bind IgE. J Clin Invest (1977) 2.37
Suppression by IgA of IgG-mediated phagocytosis by human polymorphonuclear leucocytes. Clin Exp Immunol (1978) 2.29
The binding of human immunoglobulin G1 monomer and small, covalently cross-linked polymers of immunoglobulin G1 to human peripheral blood monocytes and polymorphonuclear leukocytes. J Clin Invest (1982) 1.78
Participation of immunoglobulins and complement components in the intracellular killing of Staphylococcus aureus and Escherichia coli by human granulocytes. Infect Immun (1981) 1.74
Analysis by a plaque assay of IgG- or IgM- dependent cytolytic lymphocytes in human blood. J Exp Med (1976) 1.69
Lymphocytes with immunoglobulin E Fc receptors in patients with atopic disorders. J Clin Invest (1979) 1.49
Subpopulations of human peripheral granulocyes and monocytes express receptors for IgA. Proc Natl Acad Sci U S A (1980) 1.44
Enzyme release and superoxide anion production by human alveolar macrophages stimulated with immunoglobulin E. Clin Exp Immunol (1980) 1.42
Specificity of fc receptors for IgG2a, IgG1/IgG2b, and IgE on rat macrophages. J Exp Med (1981) 1.40
Characterization of the IgA receptor from human polymorphonuclear leucocytes. Immunology (1988) 1.39
Inhibition of human neutrophil migration by aggregated gammaglobulin. Clin Exp Immunol (1979) 1.20
Changes in quaternary structure of IgG upon reduction of the interheavy-chain disulfide bond. Proc Natl Acad Sci U S A (1979) 1.19
Phagocytic peripheral blood monocytes from rabbits and humans express membrane receptors specific for IgM molecules: evidence that incubation with neuraminidase exposes cryptic IgM (Fc) receptors. Clin Exp Immunol (1979) 1.17
Immunological studies of human placentae: subclass and fragment specificity of binding of aggregated IgG by placental endothelial cells. Immunology (1976) 1.10
Binding of immunoglobulin classes and subclasses to human neutrophils and eosinophils. Clin Exp Immunol (1986) 1.06
New insights into the enigma of immunoglobulin D. Immunol Rev (2010) 1.06
Generation of IgE-binding and IgG-binding factors from human lymphoblastoid cell lines. Immunology (1984) 1.05
Suppression of leucocyte chemokinesis and chemotaxis by human IgA. Clin Exp Immunol (1980) 1.04
Metabolism of autologous and homologous IgG in rheumatoid arthritis. J Clin Invest (1977) 1.01
Structural analysis of the N-glycans from human immunoglobulin A1: comparison of normal human serum immunoglobulin A1 with that isolated from patients with rheumatoid arthritis. Biochem J (1994) 1.00
Serum chemotactic inhibitory activity: heat activation of chemotactic inhibition. Infect Immun (1976) 1.00
Maturation-linked expression of the Fc (IgG) receptor on developing human bone marrow and peripheral blood granulocytes. Clin Exp Immunol (1979) 0.99
The absence of IgE antibody-mediated augmentation of immune responses in CD23-deficient mice. Proc Natl Acad Sci U S A (1994) 0.98
Lack of IgA subclass restriction in antibody response to phosphorylcholine, beta lactoglobulin and tetanus toxoid. Immunology (1984) 0.98
Conversion of incomplete antibodies to direct agglutinins by mild reduction: evidence for segmental flexibility within the Fc fragment of immunoglobulin G. Proc Natl Acad Sci U S A (1977) 0.98
Fc receptors for IgG, IgM and IgE on human leukaemic lymphocytes. Clin Exp Immunol (1979) 0.97
Immunoglobulin E-rheumatoid factor in the serum of patients with rheumatoid arthritis, asthma, and other diseases. J Clin Invest (1981) 0.96
Soluble immune complexes binding to human monocytes and polymorphonuclear leucocytes. Immunology (1981) 0.95
The role of Fc and C3b receptors in phagocytosis by inflammatory polymorphonuclear leucocytes in man. Immunology (1977) 0.94
Characterization of Fc receptors for IgE on human alveolar macrophages. Clin Exp Immunol (1982) 0.94
The detection of membrane and cytoplasmic immunoglobulins in human leucocytes by immunoperoxidase staining. Clin Exp Immunol (1977) 0.93
Human alveolar macrophage cytophilic immunoglobulin G-mediated phagocytosis of protein A-positive staphylococci. J Clin Invest (1982) 0.92
Direct evidence that decreased serum opsonization of Streptococcus pneumoniae via the alternative complement pathway in sickle cell disease is related to antibody deficiency. J Clin Invest (1987) 0.92
Suppressive effect of IgA soluble immune complexes on neutrophil chemotaxis. Clin Exp Immunol (1979) 0.91
The expression of Fc receptors on guinea-pig peritoneal macrophages and neutrophils. Immunology (1983) 0.89
Endocytosis and recycling of the complex between CD23 and HLA-DR in human B cells. Immunology (2001) 0.88
IgM receptors on human lymphocytes: detection by direct binding. Proc Natl Acad Sci U S A (1979) 0.88
Role of IgA and IgA fc receptors in inflammation. J Clin Immunol (2009) 0.87
Handling of soluble IgA aggregates by the mononuclear phagocytic system in mice. A comparison with IgG aggregates. Immunology (1982) 0.86
Necessity of the stalk region for immunoglobulin E interaction with CD23. Immunology (2002) 0.86
Quantitation of in vitro opsonic activity of human antibody induced by a vaccine consisting of the type III-specific polysaccharide of group B streptococcus. Infect Immun (1983) 0.85
The role of IgA and IgA Fc receptors as anti-inflammatory agents. J Clin Immunol (2010) 0.85
Immune complex receptors on cell surfaces. II. Cytochemical evaluation of their abundance on different immune cells: distribution, uptake, and regeneration. Am J Pathol (1976) 0.83
Immunoglobulin D: properties, measurement, and clinical relevance. Clin Diagn Lab Immunol (2000) 0.82
Immunoglobulin A: A next generation of therapeutic antibodies? MAbs (2011) 0.81
Human myeloma IgG half-molecules. Catabolism and biological properties. J Clin Invest (1975) 0.81
Wegener's granulomatosis: a model of auto-antibodies in mucosal autoimmunity. Clin Immunol (2009) 0.81
Detection of immunoglobulin isotypes from dried blood spots. J Immunol Methods (2013) 0.80
Suppressive effect of IgE soluble immune complex on neutrophil chemotaxis. Clin Exp Immunol (1983) 0.79
Antigenic modulation of the cytophilic binding of guinea-pig IgG and IgM antibodies to homologous macrophages. Immunology (1979) 0.79
The importance of the Fc receptors for IgA in the recognition of IgA by mouse liver cells: its comparison with carbohydrate and secretory component receptors. Immunology (1986) 0.78
Precipitated immune complexes of IgM as well as of IgG can bind to rabbit polymorphonuclear leucocytes but only the immune complexes of IgG are readily phagocytosed. Immunology (1992) 0.78
IgG subclass distribution of anti-Rh, anti-Kell and anti-Duffy antibodies measured by sensitive haemagglutination assays. Clin Exp Immunol (1987) 0.77
Studies of Fc receptors of heart valve and joint fibroblasts. Clin Exp Immunol (1981) 0.77
Serum and cerebrospinal fluid antibodies against myelin basic protein and their IgG subclass distribution in multiple sclerosis. J Neurol Neurosurg Psychiatry (1986) 0.76
Metalloprotease inhibitor-mediated inhibition of mouse immunoglobulin production. Immunology (2001) 0.75
IgD-Fc receptors on normal and neoplastic human B lymphocytes. Clin Exp Immunol (1982) 0.75
Fc receptors on human neutrophils: electron microscopic study of natural surface distribution. Immunology (1980) 0.75
Chemotactic properties of rat immunoglobulins and immune complexes. Infect Immun (1989) 0.75
From IgE to Omalizumab. J Immunol (2016) 0.75
Separation of univalent fragments from the bivalent rabbit antibody molecule by reduction of disulfide bonds. Arch Biochem Biophys (1960) 13.40
Interaction of aggregated -globulin with B lymphocytes. J Exp Med (1972) 9.29
Properties of antibodies cytophilic for macrophages. J Exp Med (1966) 8.64
Cytotoxic effects of lymphoid cells in vitro. Adv Immunol (1969) 8.18
A receptor for antibody on B lymphocytes. I. Method of detection and functional significance. J Exp Med (1972) 7.47
Red cells coated with immunoglobulin G: binding and sphering by mononuclear cells in man. Science (1967) 6.42
The adsorption of antigen by spleen cells previously treated with antiserum in vitro. Immunology (1960) 5.82
The immunologic release of constituents from neutrophil leukocytes. I. The role of antibody and complement on nonphagocytosable surfaces or phagocytosable particles. J Immunol (1971) 5.76
Receptor sites of human monocytes for IgG. Int Arch Allergy Appl Immunol (1968) 4.07
THE CATABOLISM OF HOMOLOGOUS AND HETEROLOGOUS 7S GAMMA GLOBULIN FRAGMENTS. J Exp Med (1965) 3.87
Receptors for human gamma G globulin on human neutrophils. J Clin Invest (1970) 3.79
Ca++-dependent binding of antigen-19 S antibody complexes to macrophages. J Immunol (1969) 3.70
Antibody-dependent cell-mediated cytotoxicity due to a "null" lymphoid cell. Nat New Biol (1973) 3.68
Receptors for aggregated IgG on mouse lymphocytes: their presence on thymocytes, thymus-derived, and bone marrow-derived lymphocytes. J Exp Med (1974) 3.21
The rapid induction by phytohemagglutinin of increased alpha-aminoisobutyric acid uptake by lymphocytes. J Clin Invest (1971) 2.94
Receptors on immunocompetent cells. II. Specificity and nature of receptors on dinitrophenylated guinea pig albumin- 125 I-binding lymphocytes of normal guinea pigs. J Exp Med (1971) 2.92
Mechanisms of passive sensitization. I. Presence of IgE and IgG molecules on human leukocytes. J Immunol (1970) 2.91
The release of granule enzymes from human neutrophils stimulated by aggregated immunoglobulins of different classes and subclasses. J Immunol (1972) 2.80
T cells can bind antigen via cytophilic IgM antibody made by B cells. J Immunol (1973) 1.95
The production of antisera to human gammaGlobulin subclasses in rabbits using immunological unresponsiveness. J Immunol (1968) 1.82
Macrophage cytophilic antibodies and delayed hypersensitivity. Br Med Bull (1967) 1.66
Structural studies of human gamma D myeloma protein. Biochemistry (1970) 1.66
The cytophilic activity of human immunoglobulins. J Immunol (1970) 1.55
Antigen-binding cells. I. Their idenification and role in the immune response. J Immunol (1971) 1.47
Cytophilic properties of IgA to human neutrophils. Adv Exp Med Biol (1974) 1.38
The immune response to human gamma-G-immunoglobulin in rabbits unresponsive to Fc fragment and H chain protein. J Immunol (1967) 1.25
Human reaginic antibodies. Annu Rev Med (1970) 1.11
Receptor for monomeric IgM on guinea-pig splenic macrophages. Nature (1973) 1.10
2,4-Dinitrophenyl receptors on mouse thymus and spleen cells. J Exp Med (1973) 1.07
The induction of delayed hypersensitivity by macrophage-associated antigen. The role of macrophage cytophilic antibody. Immunology (1974) 1.01
Detection of cell-absorbed protein antigen by an equilibrium diffusion method. J Immunol (1971) 0.84
Safety and antitumor activity of recombinant soluble Apo2 ligand. J Clin Invest (1999) 7.69
Biological activities of immunoglobulins of different classes and subclasses. Adv Immunol (1974) 5.22
Kinetic differences in unresponsiveness of thymus and bone marrow cells. Science (1971) 4.13
A modification of the hemolytic plaque assay for use with protein antigens. J Immunol (1968) 4.02
WISP genes are members of the connective tissue growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors. Proc Natl Acad Sci U S A (1998) 3.73
Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. Immunity (2000) 3.45
The serpin PAI-1 inhibits cell migration by blocking integrin alpha V beta 3 binding to vitronectin. Nature (1996) 3.34
Immunologic properties of bacterial lipopolysaccharide (LPS): correlation between the mitogenic, adjuvant, and immunogenic activities. J Immunol (1975) 3.18
Cellular sites of immunologic unresponsiveness. Proc Natl Acad Sci U S A (1970) 3.01
Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer. Nature (1998) 2.98
The release of granule enzymes from human neutrophils stimulated by aggregated immunoglobulins of different classes and subclasses. J Immunol (1972) 2.80
Normal embryo fibroblasts release transforming growth factors in a latent form. J Cell Physiol (1984) 2.76
Conversion of a high molecular weight latent beta-TGF from chicken embryo fibroblasts into a low molecular weight active beta-TGF under acidic conditions. Biochem Biophys Res Commun (1985) 2.75
Immunological unresponsiveness. Adv Immunol (1973) 2.75
Regulation of methionine synthesis in Salmonella typhimurium: mutants resistant to inhibition by analogues of methionine. Genetics (1968) 2.62
Relationship of the structure of bacterial lipopolysaccharides to its function in mitogenesis and adjuvanticity. Proc Natl Acad Sci U S A (1973) 2.61
Patterns of cytokine gene expression by CD4+ T cells from young and old mice. J Immunol (1993) 2.56
Recent observations and concepts in immunological unresponsiveness and autoimmunity. Clin Exp Immunol (1971) 2.45
Death receptor recruitment of endogenous caspase-10 and apoptosis initiation in the absence of caspase-8. J Biol Chem (2001) 2.40
A subpopulation of normal human peripheral B lymphcytes that bind IgE. J Clin Invest (1977) 2.37
Analysis of autoimmunity through experimental models of thyroiditis and allergic encephalomyelitis. Adv Immunol (1980) 2.27
Immunologic properties of bacterial lipopolysaccharide (LPS). II. The unresponsiveness of C3H/HeJ Mouse spleen cells to LPS-induced mitogenesis is dependent on the method used to extract LPS. J Exp Med (1975) 2.22
Purification of an inhibitor of plasminogen activator (antiactivator) synthesized by endothelial cells. J Biol Chem (1984) 2.22
Immunosuppressive actions of 1,25-dihydroxyvitamin D3: preferential inhibition of Th1 functions. J Nutr (1995) 2.15
Termination of tolerance to human gamma globulin in mice by antigen and bacterial lipopolysaccharide (endotoxin). J Exp Med (1973) 2.15
Transfer of experimental autoimmune thyroiditis by serum from thyroidectomized donors. J Exp Med (1969) 2.12
Leukocyte procoagulant activity: enhancement of production in vitro by IgG and antigen-antibody complexes. J Clin Invest (1977) 2.07
Conjugation of immunostimulatory DNA to the short ragweed allergen amb a 1 enhances its immunogenicity and reduces its allergenicity. J Allergy Clin Immunol (2000) 2.05
Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization. Proc Natl Acad Sci U S A (1996) 2.01
The production of thyroiditis and antibody following injection of unaltered thyroglobulin without adjuvant into rabbits previously stimulated with altered thyroglobulin. J Exp Med (1965) 1.96
Strand-selective repair of DNA damage in the yeast GAL7 gene requires RNA polymerase II. J Biol Chem (1992) 1.94
Neuroserpin reduces cerebral infarct volume and protects neurons from ischemia-induced apoptosis. Blood (2000) 1.90
Beta-transforming growth factor is stored in human blood platelets as a latent high molecular weight complex. Biochem Biophys Res Commun (1986) 1.90
The age-associated increase in IFN-gamma synthesis by mouse CD8+ T cells correlates with shifts in the frequencies of cell subsets defined by membrane CD44, CD45RB, 3G11, and MEL-14 expression. J Immunol (1993) 1.88
Familial dementia caused by polymerization of mutant neuroserpin. Nature (1999) 1.88
Role of IgE receptors in effector function of human eosinophils. J Immunol (1984) 1.87
The production of antisera to human gammaGlobulin subclasses in rabbits using immunological unresponsiveness. J Immunol (1968) 1.82
Studies on the induction of immunologic unresponsiveness. 3. Antigen form and mouse strain variation. J Immunol (1969) 1.81
Differences in the expression profiles of CD45RB, Pgp-1, and 3G11 membrane antigens and in the patterns of lymphokine secretion by splenic CD4+ T cells from young and aged mice. J Immunol (1990) 1.79
Further study of beta-TGFs released by virally transformed and non-transformed cells. Int J Cancer (1985) 1.77
Molecular evolution of plasminogen activator inhibitor-1 functional stability. EMBO J (1995) 1.73
Cellular events during induction of immunologic unresponsiveness in adult mice. J Immunol (1971) 1.72
Catabolism of human gammaG-immunoglobulins of different heavy chain subclasses. I. Catabolism of gammaG-myeloma proteins in man. J Clin Invest (1968) 1.71
Ultracentifuge studies of the binding of IgG of different subclasses to the Clq subunit of the first component of complement. Biochemistry (1976) 1.71
Studies on the induction of immunologic unresponsiveness. II. Kinetics. J Immunol (1967) 1.70
Cellular events in the induction of experimental allergic encephalomyelitis in rats. J Exp Med (1976) 1.69
Structural studies of human gamma D myeloma protein. Biochemistry (1970) 1.66
Release of serotonin from human platelets induced by aggregated immunoglobulins of different classes and subclasses. J Clin Invest (1973) 1.64
A serum factor in chronic hypocomplementemic hephritis distinct from immunoglobulins and activating the alternate pathway of complement. J Exp Med (1974) 1.63
Reverse fibrin autography: a method to detect and partially characterize protease inhibitors after sodium dodecyl sulfate--polyacrylamide gel electrophoresis. Anal Biochem (1984) 1.59
The cellular and subcellular bases of immunosenescence. Adv Immunol (1989) 1.59
Fc receptors for IgE on a subpopulation of human peripheral blood monocytes. J Immunol (1980) 1.59
Preferential repair of DNA damage on the transcribed strand of the human metallothionein genes requires RNA polymerase II. Mutat Res (1991) 1.58
Plasminogen activator inhibitor-1 regulates tumor growth and angiogenesis. J Biol Chem (2001) 1.58
Structure and function of Fc receptors for IgE on lymphocytes, monocytes, and macrophages. Adv Immunol (1984) 1.54
Latent beta-transforming growth factor in nontransformed and Kirsten sarcoma virus-transformed normal rat kidney cells, clone 49F. Cancer Res (1984) 1.51
B-lymphocytes activation by the Fc region of IgG. J Exp Med (1977) 1.51
The thrombomodulin analog Solulin promotes reperfusion and reduces infarct volume in a thrombotic stroke model. J Thromb Haemost (2011) 1.51
Dietary fish oil and olive oil supplementation in patients with rheumatoid arthritis. Clinical and immunologic effects. Arthritis Rheum (1990) 1.50
Cyclical production of antibody as a regulatory mechanism in the immune response. Adv Immunol (1975) 1.50
The carbohydrate contents of fragments and polypeptide chains of human gamma-G-myeloma proteins of different heavy-chain subclasses. Biochemistry (1968) 1.49
Lymphocytes with immunoglobulin E Fc receptors in patients with atopic disorders. J Clin Invest (1979) 1.49
The ability of bacterial lipopolysaccharide to modulate the induction of unresponsiveness to a state of immunity. Cellular parameters. J Exp Med (1973) 1.49
Interstitial immune complex thyroiditis in mice: the role of autoantibody to thyroglobulin. J Exp Med (1974) 1.49
Lymphokines and aging: interleukin-2 production and activity in aged animals. J Immunol (1981) 1.48
Neuroserpin, a brain-associated inhibitor of tissue plasminogen activator is localized primarily in neurons. Implications for the regulation of motor learning and neuronal survival. J Biol Chem (1997) 1.47
Studies on the induction of immunologic unresponsiveness. I. Effects of endotoxin and phytochemagglutinin. J Immunol (1967) 1.47
Effect of immunological unresponsiveness on different cell populations. Transplant Rev (1972) 1.45
IgA rheumatoid factor in the sera and saliva of patients with rheumatoid arthritis and Sjögren's syndrome. Ann Rheum Dis (1979) 1.45
Every-other-week methotrexate in patients with rheumatoid arthritis. A double-blind, placebo-controlled prospective study. Arthritis Rheum (1995) 1.44
Fc receptors specific for IgE on subpopulations of human lymphocytes and monocytes. Clin Immunol Immunopathol (1980) 1.42
Plasminogen activator inhibitor-1 contains a cryptic high affinity binding site for the low density lipoprotein receptor-related protein. J Biol Chem (1998) 1.42
Regulation of immune response by components of the complement cascade and their activated fragments. Springer Semin Immunopathol (1983) 1.41
The active conformation of plasminogen activator inhibitor 1, a target for drugs to control fibrinolysis and cell adhesion. Structure (1999) 1.40
Specificity of fc receptors for IgG2a, IgG1/IgG2b, and IgE on rat macrophages. J Exp Med (1981) 1.40
Inhibition of angiogenesis in vivo by plasminogen activator inhibitor-1. J Biol Chem (2000) 1.40
Incidence of three cross-reactive idiotypes on human rheumatoid factor paraproteins. J Immunol (1988) 1.39
Roles of T and B lymphocytes in the termination of unresponsiveness to autologous thyroglobulin in mice. J Exp Med (1974) 1.38
Cell cycle progression of glutathione-depleted human peripheral blood mononuclear cells is inhibited at S phase. J Immunol (1989) 1.38
Cytophilic properties of IgA to human neutrophils. Adv Exp Med Biol (1974) 1.38
Nonspecific activation of murine lymphocytes. I. Proliferation and polyclonal activation induced by 2-mercaptoethanol and alpha-thioglycerol. J Exp Med (1977) 1.37
Effect of chronic viral infection on the immune system. I. Comparison of the immune responsiveness of mice chronically infected with LCM virus with that of noninfected mice. J Immunol (1973) 1.36
The urokinase receptor is expressed in invasive breast cancer but not in normal breast tissue. Cancer Res (1994) 1.36
Binding of IgE myeloma proteins to human cultured lymphoblastoid cells. J Immunol (1976) 1.35
The development of autoimmune thyroiditis in rabbits following injection of aqueous preparations of heterologous thyroglobulins. J Immunol (1967) 1.35
Induction of interleukin 1 secretion and enhancement of humoral immunity by binding of human C5a to macrophage surface C5a receptors. J Exp Med (1982) 1.35
Immunologic properties of bacterial lipopolysaccharide (LPS). III. Genetic linkage between the in vitro mitogenic and in vivo adjuvant properties of LPS. J Exp Med (1976) 1.34
Cell-mediated immunity in aged mice: an underlying lesion in IL 2 synthesis. J Immunol (1982) 1.33
CD4+ T cell activation and tolerance induction in B cell knockout mice. J Exp Med (1996) 1.32
Th1 and Th2 clones differ in their response to a tolerogenic signal. J Immunol (1990) 1.31
Specific suppression of the immune response by HGG tolerant spleen cells. I. Parameters affecting the level of suppression. J Immunol (1976) 1.30
Induction and mode of action of suppressor cells generated against human gamma globulin. I. An immunologic unresponsive state devoid of demonstrable suppressor cells. J Exp Med (1978) 1.29
Transfer of experimental autoimmune thyroiditis with T cell clones. J Immunol (1987) 1.28
Demonstration of a specific receptor for human C5a anaphylatoxin on murine macrophages. J Exp Med (1982) 1.28
Tolerogenicity of resting and activated B cells. J Exp Med (1994) 1.25
The immune response to human gamma-G-immunoglobulin in rabbits unresponsive to Fc fragment and H chain protein. J Immunol (1967) 1.25